TRIO ART-OPTIMISATION
@TRIO_ARToptim
Followers
35
Following
37
Media
16
Statuses
26
TRIO: LONG-TERM EVALUATION OF RISK-BENEFIT FOR DOLUTEGRAVIR IN THREE RANDOMISED TRIALS ADVANCE, DolPHIN 2 and NAMSAL-ANRS 12313 trials
Joined July 2022
Pooled data analysis from three large-scale clinical trials reveal long-term effects of dolutegravir-based treatment regimens on people living with HIV
unitaid.org
Montreal, 30 July 2022 – Joint analysis from three HIV clinical research studies investigating the long-term effects of dolutegravir-based antiretroviral treatment regimens at 192 weeks’ follow-up...
0
2
4
Earlier in May, Unitaid announced new estimates projecting US$7 billion in savings to health systems by 2030, resulting from the rapid and widescale implementation of a groundbreaking treatment for HIV, dolutegravir. Find out more: https://t.co/4s9PVjnQhk
0
6
6
Chief investigator Prof Saye Khoo is participating in Enabling the ecosystem to accelerate HIV treatment optimization: Reflecting on what’s worked, what hasn’t, and looking ahead at #IAS2023 discussing the successes in DolPHIN2 and TRIO
0
9
25
Nkuli Mashabane, clinical trialist extraordinaire, taking us through the ADVANCE trial planning. @INTERESTconf
0
2
14
Unitaid’s ART optimization portfolio ensures end-to-end approach to tackle access barriers to new optimal ARV’s- Pamela Nawaggi from Unitaid @INTERESTconf @UNITAID @ezintsha @LivUni @namsal
0
0
1
The @UNITAID funded ART Optimization portfolio has produced great lessons on conducting clinical trials in Africa. Join us @INTERESTconf on 11 May at 18:00. @aidsmap @ezintsha @agenceANRS @LivUni #INTEREST2023 #HIV #Mozambique
0
2
1
Join us on Thursday 11 May at this year’s #INTEREST for our special session. @FrancoisVenter3 @ezintsha @agenceANRS @UNITAID @LivUni
0
0
2
💊 New comedications added to the HIV site Dronedarone (Antiarrhythmics) Apalutamide (Cancer therapies) Bempedoic acid, Icosapent ethyl, Omega-3 fatty acids (Lipid Lowering Agents) Omega-3 fatty acids [in multivitamins] (Herbals/Supplements/Vitamins) Tirzepatide (Anti-diabetics)
1
6
7
The #HIV response requires a bold champion to help avert millions of needlessly lost lives. I cordially invite you, @JustinTrudeau, to address the global HIV community at the #AIDS2022 closing ceremony to outline your vision for the HIV response at home and around the world.
7
142
282
People watts to learn
#HappeningNow #AIDS2022 @AIDS_conference @TRIO_ARToptim @UoLDolphin2 @agenceANRS session in the Global Village. Come and hear from study participants and team members.
0
0
1
HAPPENING NOW At Globalvillage. @TRIO_ARToptim @AIDS_conference @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi #AIDS2022
0
0
5
Thank you 🙏 very much to joined @TRIO_ARToptim during the satellite symposium @AIDS_conference @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi
0
2
5
TRIO SYMPOSIUM Closing remarks!! ,@TRIO_ARToptim @AIDS_conference @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi #AIDS2022
0
2
8
TRIO SYMPOSIUM presentation going on!!! Picture @TRIO_ARToptim @AIDS_conference @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi #AIDS2022
0
1
5
TRIO SYMPOSIUM Live!ĺĺ Transition from clinical trial to national programme @TRIO_ARToptim @AIDS_conference @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi #AIDS2022
0
2
6
TRIO SYMPOSIUM Move to session 2: Community engagement @TRIO_ARToptim @AIDS_conference @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi #AIDS2022
0
2
6
LIVE ! TRIO Symposium Treatment Optimisation: lessons from TRIO- ADVANCE, DOLPHIN2 AND NAMSAL- ANRS-12313 trial funded by UNITAID @TRIO_ARToptim @AIDS_conference @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi #AIDS2022
0
1
6
HAPPENING NOW!!! @TRIO_ARToptim satellite symposium @AIDS_conference -room 517c/channel 4 @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi #AIDS2022
0
5
14
#AIDS2022 En cours: Soirée des partenaires France sur comment le partenariat du Fonds Mondial participe de la résilience des systèmes de santé en contexte de crise. Modéré par Michel Kazatchkine, conseiller spécial de l’OMS-EUROPE
0
2
3